nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP19A1—Betamethasone—multiple sclerosis	0.194	0.263	CbGbCtD
Letrozole—CYP2A6—Prednisolone—multiple sclerosis	0.121	0.164	CbGbCtD
Letrozole—CYP19A1—Dexamethasone—multiple sclerosis	0.113	0.153	CbGbCtD
Letrozole—CYP2A6—Dexamethasone—multiple sclerosis	0.0716	0.0968	CbGbCtD
Letrozole—CYP3A4—Fingolimod—multiple sclerosis	0.0588	0.0794	CbGbCtD
Letrozole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0379	0.0512	CbGbCtD
Letrozole—CYP3A4—Triamcinolone—multiple sclerosis	0.0287	0.0388	CbGbCtD
Letrozole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0276	0.0373	CbGbCtD
Letrozole—CYP3A4—Betamethasone—multiple sclerosis	0.0246	0.0333	CbGbCtD
Letrozole—CYP3A4—Prednisolone—multiple sclerosis	0.0243	0.0328	CbGbCtD
Letrozole—CYP3A4—Prednisone—multiple sclerosis	0.0229	0.031	CbGbCtD
Letrozole—CYP3A4—Dexamethasone—multiple sclerosis	0.0143	0.0194	CbGbCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.000621	0.0605	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.000621	0.0605	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000385	0.0375	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000385	0.0375	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00038	0.037	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00038	0.037	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000375	0.0365	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000312	0.0304	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000312	0.0304	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000307	0.0299	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000307	0.0299	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000303	0.0295	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000303	0.0295	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000298	0.029	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000249	0.0242	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000249	0.0242	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000243	0.0237	CbGpPWpGaD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000211	0.000842	CcSEcCtD
Letrozole—Dermatitis—Azathioprine—multiple sclerosis	0.00021	0.000841	CcSEcCtD
Letrozole—Depression—Methotrexate—multiple sclerosis	0.00021	0.000841	CcSEcCtD
Letrozole—Flushing—Prednisone—multiple sclerosis	0.00021	0.000841	CcSEcCtD
Letrozole—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00021	0.00084	CcSEcCtD
Letrozole—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00021	0.00084	CcSEcCtD
Letrozole—Discomfort—Triamcinolone—multiple sclerosis	0.00021	0.000839	CcSEcCtD
Letrozole—Discomfort—Methylprednisolone—multiple sclerosis	0.000209	0.000838	CcSEcCtD
Letrozole—Headache—Azathioprine—multiple sclerosis	0.000209	0.000837	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000208	0.0203	CbGpPWpGaD
Letrozole—Dry mouth—Triamcinolone—multiple sclerosis	0.000208	0.000831	CcSEcCtD
Letrozole—Angioedema—Betamethasone—multiple sclerosis	0.000207	0.000827	CcSEcCtD
Letrozole—Angioedema—Dexamethasone—multiple sclerosis	0.000207	0.000827	CcSEcCtD
Letrozole—Stomatitis—Methotrexate—multiple sclerosis	0.000206	0.000822	CcSEcCtD
Letrozole—Angiopathy—Prednisone—multiple sclerosis	0.000206	0.000822	CcSEcCtD
Letrozole—Malaise—Betamethasone—multiple sclerosis	0.000204	0.000817	CcSEcCtD
Letrozole—Malaise—Dexamethasone—multiple sclerosis	0.000204	0.000817	CcSEcCtD
Letrozole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000204	0.000814	CcSEcCtD
Letrozole—Oedema—Triamcinolone—multiple sclerosis	0.000204	0.000814	CcSEcCtD
Letrozole—Vertigo—Dexamethasone—multiple sclerosis	0.000203	0.000814	CcSEcCtD
Letrozole—Vertigo—Betamethasone—multiple sclerosis	0.000203	0.000814	CcSEcCtD
Letrozole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000203	0.000813	CcSEcCtD
Letrozole—Infection—Triamcinolone—multiple sclerosis	0.000202	0.000809	CcSEcCtD
Letrozole—Sweating—Methotrexate—multiple sclerosis	0.000202	0.000809	CcSEcCtD
Letrozole—Infection—Methylprednisolone—multiple sclerosis	0.000202	0.000807	CcSEcCtD
Letrozole—Insomnia—Prednisolone—multiple sclerosis	0.0002	0.000801	CcSEcCtD
Letrozole—Alopecia—Prednisone—multiple sclerosis	0.0002	0.0008	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000199	0.000798	CcSEcCtD
Letrozole—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000199	0.000797	CcSEcCtD
Letrozole—Paraesthesia—Prednisolone—multiple sclerosis	0.000199	0.000795	CcSEcCtD
Letrozole—Tachycardia—Triamcinolone—multiple sclerosis	0.000199	0.000795	CcSEcCtD
Letrozole—Mental disorder—Prednisone—multiple sclerosis	0.000198	0.000794	CcSEcCtD
Letrozole—Nausea—Azathioprine—multiple sclerosis	0.000198	0.000793	CcSEcCtD
Letrozole—Tachycardia—Methylprednisolone—multiple sclerosis	0.000198	0.000793	CcSEcCtD
Letrozole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000197	0.000789	CcSEcCtD
Letrozole—Malnutrition—Prednisone—multiple sclerosis	0.000197	0.000789	CcSEcCtD
Letrozole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000197	0.000787	CcSEcCtD
Letrozole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000196	0.000786	CcSEcCtD
Letrozole—Hypertension—Dexamethasone—multiple sclerosis	0.000195	0.000782	CcSEcCtD
Letrozole—Hypertension—Betamethasone—multiple sclerosis	0.000195	0.000782	CcSEcCtD
Letrozole—Asthenia—Mitoxantrone—multiple sclerosis	0.000194	0.000775	CcSEcCtD
Letrozole—Myalgia—Betamethasone—multiple sclerosis	0.000193	0.000771	CcSEcCtD
Letrozole—Myalgia—Dexamethasone—multiple sclerosis	0.000193	0.000771	CcSEcCtD
Letrozole—Anxiety—Betamethasone—multiple sclerosis	0.000192	0.000768	CcSEcCtD
Letrozole—Anxiety—Dexamethasone—multiple sclerosis	0.000192	0.000768	CcSEcCtD
Letrozole—Discomfort—Betamethasone—multiple sclerosis	0.00019	0.000762	CcSEcCtD
Letrozole—Discomfort—Dexamethasone—multiple sclerosis	0.00019	0.000762	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—multiple sclerosis	0.00019	0.000761	CcSEcCtD
Letrozole—Pain—Prednisolone—multiple sclerosis	0.000189	0.000757	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—multiple sclerosis	0.000189	0.000757	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—multiple sclerosis	0.000189	0.000757	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000187	0.000748	CcSEcCtD
Letrozole—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000187	0.0182	CbGpPWpGaD
Letrozole—Vision blurred—Prednisone—multiple sclerosis	0.000186	0.000743	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—multiple sclerosis	0.000186	0.000742	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000186	0.000742	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000185	0.00074	CcSEcCtD
Letrozole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000185	0.000739	CcSEcCtD
Letrozole—Oedema—Dexamethasone—multiple sclerosis	0.000185	0.000739	CcSEcCtD
Letrozole—Oedema—Betamethasone—multiple sclerosis	0.000185	0.000739	CcSEcCtD
Letrozole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000185	0.000739	CcSEcCtD
Letrozole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000185	0.000739	CcSEcCtD
Letrozole—Insomnia—Triamcinolone—multiple sclerosis	0.000184	0.000737	CcSEcCtD
Letrozole—Insomnia—Methylprednisolone—multiple sclerosis	0.000184	0.000735	CcSEcCtD
Letrozole—Infection—Betamethasone—multiple sclerosis	0.000184	0.000734	CcSEcCtD
Letrozole—Infection—Dexamethasone—multiple sclerosis	0.000184	0.000734	CcSEcCtD
Letrozole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000183	0.000732	CcSEcCtD
Letrozole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000183	0.000731	CcSEcCtD
Letrozole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000183	0.00073	CcSEcCtD
Letrozole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000182	0.00073	CcSEcCtD
Letrozole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000182	0.000726	CcSEcCtD
Letrozole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000181	0.000725	CcSEcCtD
Letrozole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000181	0.000725	CcSEcCtD
Letrozole—Tachycardia—Dexamethasone—multiple sclerosis	0.00018	0.000721	CcSEcCtD
Letrozole—Tachycardia—Betamethasone—multiple sclerosis	0.00018	0.000721	CcSEcCtD
Letrozole—Angioedema—Prednisone—multiple sclerosis	0.00018	0.000721	CcSEcCtD
Letrozole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000179	0.000717	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000179	0.000716	CcSEcCtD
Letrozole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000179	0.000715	CcSEcCtD
Letrozole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000179	0.000714	CcSEcCtD
Letrozole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000179	0.000714	CcSEcCtD
Letrozole—Malaise—Prednisone—multiple sclerosis	0.000178	0.000711	CcSEcCtD
Letrozole—Vertigo—Prednisone—multiple sclerosis	0.000177	0.000708	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000177	0.0172	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000177	0.0172	CbGpPWpGaD
Letrozole—Eye disorder—Methotrexate—multiple sclerosis	0.000177	0.000708	CcSEcCtD
Letrozole—Anorexia—Betamethasone—multiple sclerosis	0.000176	0.000704	CcSEcCtD
Letrozole—Anorexia—Dexamethasone—multiple sclerosis	0.000176	0.000704	CcSEcCtD
Letrozole—Urticaria—Prednisolone—multiple sclerosis	0.000176	0.000704	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—multiple sclerosis	0.000176	0.000703	CcSEcCtD
Letrozole—Fatigue—Triamcinolone—multiple sclerosis	0.000176	0.000702	CcSEcCtD
Letrozole—Fatigue—Methylprednisolone—multiple sclerosis	0.000175	0.000701	CcSEcCtD
Letrozole—Pain—Triamcinolone—multiple sclerosis	0.000174	0.000697	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—multiple sclerosis	0.000172	0.000687	CcSEcCtD
Letrozole—Vomiting—Mitoxantrone—multiple sclerosis	0.000172	0.000686	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000171	0.000682	CcSEcCtD
Letrozole—Hypertension—Prednisone—multiple sclerosis	0.00017	0.000681	CcSEcCtD
Letrozole—Rash—Mitoxantrone—multiple sclerosis	0.00017	0.000681	CcSEcCtD
Letrozole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00017	0.00068	CcSEcCtD
Letrozole—Headache—Mitoxantrone—multiple sclerosis	0.000169	0.000676	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000168	0.000673	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000168	0.000673	CcSEcCtD
Letrozole—Arthralgia—Prednisone—multiple sclerosis	0.000168	0.000671	CcSEcCtD
Letrozole—Myalgia—Prednisone—multiple sclerosis	0.000168	0.000671	CcSEcCtD
Letrozole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000168	0.000671	CcSEcCtD
Letrozole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000167	0.00067	CcSEcCtD
Letrozole—Anxiety—Prednisone—multiple sclerosis	0.000167	0.000669	CcSEcCtD
Letrozole—Alopecia—Methotrexate—multiple sclerosis	0.000167	0.000669	CcSEcCtD
Letrozole—Insomnia—Dexamethasone—multiple sclerosis	0.000167	0.000668	CcSEcCtD
Letrozole—Insomnia—Betamethasone—multiple sclerosis	0.000167	0.000668	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000167	0.000667	CcSEcCtD
Letrozole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000166	0.000665	CcSEcCtD
Letrozole—Paraesthesia—Betamethasone—multiple sclerosis	0.000166	0.000664	CcSEcCtD
Letrozole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000166	0.000664	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000166	0.0162	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000166	0.0162	CbGpPWpGaD
Letrozole—Discomfort—Prednisone—multiple sclerosis	0.000166	0.000663	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—multiple sclerosis	0.000166	0.000663	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—multiple sclerosis	0.000165	0.000659	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000164	0.0159	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000164	0.0159	CbGpPWpGaD
Letrozole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000163	0.000651	CcSEcCtD
Letrozole—Dyspepsia—Betamethasone—multiple sclerosis	0.000163	0.000651	CcSEcCtD
Letrozole—Urticaria—Triamcinolone—multiple sclerosis	0.000162	0.000647	CcSEcCtD
Letrozole—Urticaria—Methylprednisolone—multiple sclerosis	0.000161	0.000646	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—multiple sclerosis	0.000161	0.000645	CcSEcCtD
Letrozole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000161	0.000644	CcSEcCtD
Letrozole—Oedema—Prednisone—multiple sclerosis	0.000161	0.000644	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000161	0.000644	CcSEcCtD
Letrozole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000161	0.000642	CcSEcCtD
Letrozole—Decreased appetite—Betamethasone—multiple sclerosis	0.000161	0.000642	CcSEcCtD
Letrozole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000161	0.000642	CcSEcCtD
Letrozole—Nausea—Mitoxantrone—multiple sclerosis	0.00016	0.000641	CcSEcCtD
Letrozole—Infection—Prednisone—multiple sclerosis	0.00016	0.000639	CcSEcCtD
Letrozole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00016	0.000638	CcSEcCtD
Letrozole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00016	0.000638	CcSEcCtD
Letrozole—Back pain—Methotrexate—multiple sclerosis	0.000159	0.000637	CcSEcCtD
Letrozole—Fatigue—Dexamethasone—multiple sclerosis	0.000159	0.000637	CcSEcCtD
Letrozole—Fatigue—Betamethasone—multiple sclerosis	0.000159	0.000637	CcSEcCtD
Letrozole—Pain—Dexamethasone—multiple sclerosis	0.000158	0.000632	CcSEcCtD
Letrozole—Pain—Betamethasone—multiple sclerosis	0.000158	0.000632	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—multiple sclerosis	0.000158	0.000631	CcSEcCtD
Letrozole—Tachycardia—Prednisone—multiple sclerosis	0.000157	0.000628	CcSEcCtD
Letrozole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000157	0.0153	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000157	0.0152	CbGpPWpGaD
Letrozole—Skin disorder—Prednisone—multiple sclerosis	0.000156	0.000625	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—multiple sclerosis	0.000156	0.000622	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—multiple sclerosis	0.000155	0.000621	CcSEcCtD
Letrozole—Anorexia—Prednisone—multiple sclerosis	0.000153	0.000613	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000153	0.000611	CcSEcCtD
Letrozole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000152	0.000609	CcSEcCtD
Letrozole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000152	0.000609	CcSEcCtD
Letrozole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000151	0.000604	CcSEcCtD
Letrozole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000151	0.000604	CcSEcCtD
Letrozole—Malaise—Methotrexate—multiple sclerosis	0.000149	0.000594	CcSEcCtD
Letrozole—Vertigo—Methotrexate—multiple sclerosis	0.000148	0.000592	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—multiple sclerosis	0.000148	0.00059	CcSEcCtD
Letrozole—Urticaria—Dexamethasone—multiple sclerosis	0.000147	0.000587	CcSEcCtD
Letrozole—Urticaria—Betamethasone—multiple sclerosis	0.000147	0.000587	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000147	0.000586	CcSEcCtD
Letrozole—Dizziness—Prednisolone—multiple sclerosis	0.000146	0.000586	CcSEcCtD
Letrozole—Asthenia—Triamcinolone—multiple sclerosis	0.000146	0.000584	CcSEcCtD
Letrozole—Abdominal pain—Betamethasone—multiple sclerosis	0.000146	0.000584	CcSEcCtD
Letrozole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000146	0.000584	CcSEcCtD
Letrozole—Body temperature increased—Betamethasone—multiple sclerosis	0.000146	0.000584	CcSEcCtD
Letrozole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000146	0.000584	CcSEcCtD
Letrozole—Asthenia—Methylprednisolone—multiple sclerosis	0.000146	0.000583	CcSEcCtD
Letrozole—Insomnia—Prednisone—multiple sclerosis	0.000146	0.000582	CcSEcCtD
Letrozole—Paraesthesia—Prednisone—multiple sclerosis	0.000145	0.000578	CcSEcCtD
Letrozole—Pruritus—Triamcinolone—multiple sclerosis	0.000144	0.000576	CcSEcCtD
Letrozole—Cough—Methotrexate—multiple sclerosis	0.000144	0.000575	CcSEcCtD
Letrozole—Pruritus—Methylprednisolone—multiple sclerosis	0.000144	0.000575	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—multiple sclerosis	0.000142	0.000567	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—multiple sclerosis	0.00014	0.000561	CcSEcCtD
Letrozole—Chest pain—Methotrexate—multiple sclerosis	0.00014	0.000561	CcSEcCtD
Letrozole—Myalgia—Methotrexate—multiple sclerosis	0.00014	0.000561	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—multiple sclerosis	0.00014	0.000559	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00014	0.0136	CbGpPWpGaD
Letrozole—Rash—Prednisolone—multiple sclerosis	0.00014	0.000558	CcSEcCtD
Letrozole—Dermatitis—Prednisolone—multiple sclerosis	0.00014	0.000558	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000139	0.000557	CcSEcCtD
Letrozole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000139	0.000556	CcSEcCtD
Letrozole—Fatigue—Prednisone—multiple sclerosis	0.000139	0.000555	CcSEcCtD
Letrozole—Headache—Prednisolone—multiple sclerosis	0.000139	0.000555	CcSEcCtD
Letrozole—Discomfort—Methotrexate—multiple sclerosis	0.000139	0.000554	CcSEcCtD
Letrozole—Constipation—Prednisone—multiple sclerosis	0.000138	0.00055	CcSEcCtD
Letrozole—Dizziness—Triamcinolone—multiple sclerosis	0.000135	0.000539	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000134	0.000538	CcSEcCtD
Letrozole—Dizziness—Methylprednisolone—multiple sclerosis	0.000134	0.000537	CcSEcCtD
Letrozole—Infection—Methotrexate—multiple sclerosis	0.000134	0.000534	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—multiple sclerosis	0.000133	0.00053	CcSEcCtD
Letrozole—Asthenia—Dexamethasone—multiple sclerosis	0.000133	0.00053	CcSEcCtD
Letrozole—Asthenia—Betamethasone—multiple sclerosis	0.000133	0.00053	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000132	0.0129	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000132	0.0129	CbGpPWpGaD
Letrozole—Nervous system disorder—Methotrexate—multiple sclerosis	0.000132	0.000527	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000132	0.000526	CcSEcCtD
Letrozole—Nausea—Prednisolone—multiple sclerosis	0.000132	0.000526	CcSEcCtD
Letrozole—Pruritus—Dexamethasone—multiple sclerosis	0.000131	0.000523	CcSEcCtD
Letrozole—Pruritus—Betamethasone—multiple sclerosis	0.000131	0.000523	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—multiple sclerosis	0.000131	0.000522	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00013	0.00052	CcSEcCtD
Letrozole—Vomiting—Triamcinolone—multiple sclerosis	0.000129	0.000518	CcSEcCtD
Letrozole—Vomiting—Methylprednisolone—multiple sclerosis	0.000129	0.000517	CcSEcCtD
Letrozole—Rash—Triamcinolone—multiple sclerosis	0.000128	0.000514	CcSEcCtD
Letrozole—Dermatitis—Triamcinolone—multiple sclerosis	0.000128	0.000513	CcSEcCtD
Letrozole—Anorexia—Methotrexate—multiple sclerosis	0.000128	0.000513	CcSEcCtD
Letrozole—Rash—Methylprednisolone—multiple sclerosis	0.000128	0.000512	CcSEcCtD
Letrozole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000128	0.000512	CcSEcCtD
Letrozole—Urticaria—Prednisone—multiple sclerosis	0.000128	0.000511	CcSEcCtD
Letrozole—Headache—Triamcinolone—multiple sclerosis	0.000128	0.00051	CcSEcCtD
Letrozole—Headache—Methylprednisolone—multiple sclerosis	0.000127	0.000509	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—multiple sclerosis	0.000127	0.000509	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—multiple sclerosis	0.000127	0.000509	CcSEcCtD
Letrozole—Diarrhoea—Betamethasone—multiple sclerosis	0.000126	0.000506	CcSEcCtD
Letrozole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000126	0.000506	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000123	0.00049	CcSEcCtD
Letrozole—Dizziness—Dexamethasone—multiple sclerosis	0.000122	0.000489	CcSEcCtD
Letrozole—Dizziness—Betamethasone—multiple sclerosis	0.000122	0.000489	CcSEcCtD
Letrozole—Insomnia—Methotrexate—multiple sclerosis	0.000122	0.000486	CcSEcCtD
Letrozole—Nausea—Triamcinolone—multiple sclerosis	0.000121	0.000484	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—multiple sclerosis	0.000121	0.000483	CcSEcCtD
Letrozole—Nausea—Methylprednisolone—multiple sclerosis	0.000121	0.000483	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—multiple sclerosis	0.00012	0.00048	CcSEcCtD
Letrozole—Somnolence—Methotrexate—multiple sclerosis	0.00012	0.000478	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—multiple sclerosis	0.000118	0.000473	CcSEcCtD
Letrozole—Vomiting—Betamethasone—multiple sclerosis	0.000117	0.00047	CcSEcCtD
Letrozole—Vomiting—Dexamethasone—multiple sclerosis	0.000117	0.00047	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—multiple sclerosis	0.000117	0.000468	CcSEcCtD
Letrozole—Rash—Betamethasone—multiple sclerosis	0.000117	0.000466	CcSEcCtD
Letrozole—Rash—Dexamethasone—multiple sclerosis	0.000117	0.000466	CcSEcCtD
Letrozole—Dermatitis—Betamethasone—multiple sclerosis	0.000116	0.000466	CcSEcCtD
Letrozole—Dermatitis—Dexamethasone—multiple sclerosis	0.000116	0.000466	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000116	0.000464	CcSEcCtD
Letrozole—Fatigue—Methotrexate—multiple sclerosis	0.000116	0.000464	CcSEcCtD
Letrozole—Headache—Betamethasone—multiple sclerosis	0.000116	0.000463	CcSEcCtD
Letrozole—Headache—Dexamethasone—multiple sclerosis	0.000116	0.000463	CcSEcCtD
Letrozole—Asthenia—Prednisone—multiple sclerosis	0.000115	0.000462	CcSEcCtD
Letrozole—Pain—Methotrexate—multiple sclerosis	0.000115	0.00046	CcSEcCtD
Letrozole—Pruritus—Prednisone—multiple sclerosis	0.000114	0.000455	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000112	0.0109	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000112	0.0109	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000111	0.0108	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000111	0.0108	CbGpPWpGaD
Letrozole—Feeling abnormal—Methotrexate—multiple sclerosis	0.000111	0.000443	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—multiple sclerosis	0.00011	0.00044	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00011	0.00044	CcSEcCtD
Letrozole—Nausea—Betamethasone—multiple sclerosis	0.00011	0.000439	CcSEcCtD
Letrozole—Nausea—Dexamethasone—multiple sclerosis	0.00011	0.000439	CcSEcCtD
Letrozole—Urticaria—Methotrexate—multiple sclerosis	0.000107	0.000427	CcSEcCtD
Letrozole—Dizziness—Prednisone—multiple sclerosis	0.000106	0.000426	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—multiple sclerosis	0.000106	0.000425	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—multiple sclerosis	0.000106	0.000425	CcSEcCtD
Letrozole—Vomiting—Prednisone—multiple sclerosis	0.000102	0.000409	CcSEcCtD
Letrozole—Rash—Prednisone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Letrozole—Dermatitis—Prednisone—multiple sclerosis	0.000101	0.000405	CcSEcCtD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000101	0.00982	CbGpPWpGaD
Letrozole—Headache—Prednisone—multiple sclerosis	0.000101	0.000403	CcSEcCtD
Letrozole—Asthenia—Methotrexate—multiple sclerosis	9.65e-05	0.000386	CcSEcCtD
Letrozole—Nausea—Prednisone—multiple sclerosis	9.56e-05	0.000382	CcSEcCtD
Letrozole—Pruritus—Methotrexate—multiple sclerosis	9.52e-05	0.000381	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	9.28e-05	0.00904	CbGpPWpGaD
Letrozole—Diarrhoea—Methotrexate—multiple sclerosis	9.2e-05	0.000368	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.11e-05	0.00887	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.11e-05	0.00887	CbGpPWpGaD
Letrozole—Dizziness—Methotrexate—multiple sclerosis	8.89e-05	0.000356	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.67e-05	0.00844	CbGpPWpGaD
Letrozole—Vomiting—Methotrexate—multiple sclerosis	8.55e-05	0.000342	CcSEcCtD
Letrozole—Rash—Methotrexate—multiple sclerosis	8.48e-05	0.000339	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—multiple sclerosis	8.47e-05	0.000339	CcSEcCtD
Letrozole—Headache—Methotrexate—multiple sclerosis	8.43e-05	0.000337	CcSEcCtD
Letrozole—Nausea—Methotrexate—multiple sclerosis	7.99e-05	0.000319	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.02e-05	0.00684	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.9e-05	0.00672	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.37e-05	0.0062	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.37e-05	0.0062	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.79e-05	0.00564	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.59e-05	0.00544	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.84e-05	0.00471	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.84e-05	0.00471	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.77e-05	0.00465	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.77e-05	0.00465	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SRM—multiple sclerosis	4.03e-05	0.00392	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—POMC—multiple sclerosis	3.73e-05	0.00363	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SRM—multiple sclerosis	3.2e-05	0.00312	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—POMC—multiple sclerosis	2.97e-05	0.00289	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	2.84e-05	0.00276	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	2.84e-05	0.00276	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.77e-05	0.0027	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPC5—multiple sclerosis	2.59e-05	0.00253	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.53e-05	0.00246	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.39e-05	0.00233	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.34e-05	0.00228	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.26e-05	0.0022	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.26e-05	0.0022	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—RRM1—multiple sclerosis	2.15e-05	0.00209	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.07e-05	0.00201	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.05e-05	0.002	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	1.95e-05	0.0019	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.00167	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.67e-05	0.00162	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.43e-05	0.0014	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.31e-05	0.00127	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.0012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SRM—multiple sclerosis	1.17e-05	0.00114	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.09e-05	0.00106	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCHE—multiple sclerosis	9.83e-06	0.000957	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.28e-06	0.000806	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.28e-06	0.000806	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.57e-06	0.000737	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—multiple sclerosis	7.43e-06	0.000723	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—POMC—multiple sclerosis	6.38e-06	0.000621	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.27e-06	0.000611	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—multiple sclerosis	5.91e-06	0.000576	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—multiple sclerosis	5.82e-06	0.000567	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—POMC—multiple sclerosis	5.08e-06	0.000495	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—multiple sclerosis	4.63e-06	0.000451	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.6e-06	0.000351	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—multiple sclerosis	2.17e-06	0.000211	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—POMC—multiple sclerosis	1.86e-06	0.000181	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—multiple sclerosis	1.7e-06	0.000165	CbGpPWpGaD
